NEOGENOMICS NEWS

NeoGenomics Announces the Opening of its
First International Laboratory near Geneva,
Switzerland to Support Clinical Trials

Read More

Comprehensive Immuno-Oncology Testing

Explore More CDx Options with All Currently Available
PD-L1 IVDs, Tumor Mutation Burden, MSI, and MMR

Learn More

Online%20test%20Ordering

What are the top five ways

Online Test Ordering

can improve your day and your workflow?

Answers Here

Pharma Services

Pharma Services

NeoGenomics offers lab services for oncology clinical trials

Learn more 

NeoGenomics Industy Events

Upcoming Events

Meet with NeoGenomics at an upcoming tradeshow

Click here to view

HER-2%20Breast%20FISH

Global Capabilities

Learn about our unique service offerings that are now available globally

Read now

KRAS%20BRAF%20EGFR%20Mutation

New Research Paper in Journal of Cancer

A Multi-Center Prospective Study to Validate an Algorithm Using Urine and Plasma Biomarkers for Predicting Gleason ≥3+4 Prostate Cancer on Biopsy

Read now

HER-2%20Breast%20FISH

NeoGenomics Reports Record Revenue of $66.1 Million on 16% Volume Growth and 13% Reduction in Average Cost per Test in the Second Quarter of 2017

Read press release

KRAS%20BRAF%20EGFR%20Mutation

New Article in Springer Nature

Detecting BRAF, KRAS, and EGFR Mutations via NGS vs. PCR-based Kits

Read now

HER-2%20Breast%20FISH

NeoGenomics Announces Expansion of Immuno-Oncology Profiling Tests

Read press release

HER-2%20Breast%20FISH

NeoGenomics Reports that its NeoLAB® Liquid Biopsy Prostate Test is More Accurate than Conventional Biopsies in Predicting High Grade Prostate Cancer

Read press release

Plasma%20Cell%20Myeloma

Updates in Plasma Cell Myeloma Testing

Hosted by Dr. Adrian Padurean
Date: Wednesday, December 6, 2017
Time: 2 to 3 pm ET, 11 am to Noon PT

Click here to register>

CDKN2A%20(p16)%20Deletion

CDKN2A p16 Deletion for Mesothelioma

To help distinguish malignant mesothelioma vs. reactive mesothelial hyperplasia and epithelial ovarian cancer

Learn more

Universal%20Fusion

NeoTYPE® GI Predictive Profile

RAS/RAF, MSI, HER2, and PD-L1 to maximize options for therapy in GI cancers

Learn more

NeoLab%20EGFR

NeoLABTM EGFR T790M Liquid Biopsy

Learn more

Accurate and sensitive detection of the EGFR T790M mutation using cell-free plasma DNA

Universal%20Fusion

Universal Fusion/Expression Profile

Broad detection of fusion transcripts and gene expression in 1385 cancer genes

Learn more

PD-L1-22C3-IHC-for-Gastric%25252FGEA

PD-L1 22C3 IHC for Gastric/GEA

PD-L1 22C3 pharmDx™ for Gastric & Gastroesophageal Junction Adenocarcinoma (GEJ/GEA)

Learn more